Healthy volunteers help uncover Vamorolone's enzyme effects
NCT ID NCT06689527
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a medicine called vamorolone affects a key liver enzyme (CYP3A4) that processes many drugs. Eighteen healthy adults took a single dose of midazolam before and after 14 days of vamorolone to see if vamorolone changed how midazolam was handled. The results help doctors understand potential drug interactions when using vamorolone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG INTERACTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nuvisan GmbH
Neu-Ulm, 89231, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Pfizer tests experimental drug to slow stomach emptying in obesity
- Study reveals hidden risks of mixing Beta-Blockers and Anti-Inflammatories
- New Gel's drug interactions revealed in healthy volunteer study
- New computer tool aims to catch dangerous drug mixes in older patients
- Gene study aims to predict chemo side effects in kids with leukemia
- New study aims to predict dangerous side effects of common breast cancer drugs